“…After 4 years, 40 % of the patients in the placebo group either died or had end-stage renal disease, whereas only 10 % of the patients in the FO group showed progression of disease. It appears that purified FO with antioxidant supplements may inhibit or delay the progression of renal disease by altering the production of pro-inflammatory cytokines, growth factors, and PG, perhaps decreasing activation and localization of complement, which may suppress deposition of antigen-antibody complexes in glomeruli (DeCaterina et al 1993(DeCaterina et al , 1994Gentile et al 1993;Nordkild et al 1993;Donadio et al 1994;Lin, 1994;Morphake et al 1994;Petterson et al 1994).…”